In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

Hibiscus sabdariffa L. (Family: Malvaceae) is believed to be domesticated by the people of western Sudan sometime before 4000 BC for their nutritional and medicinal properties. This study aimed to ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

With the summer heat settling in across Alabama, state health officials are sharing tips to help you understand the warning ...

Perfuse Therapeutics shares positive results from Phase 2 clinical trials of PER-001 By Sydney M Crago June 26th 2025 Successful phase 1B study of oral therapy for diabetic retinopathy ...

Reports on the clash between the presidency and the African Democratic Congress (ADC), as the race for the 2027 presidency gathers momentum, perfuse the frontpages. New Telegraph reports that the ...

PER-001 (Perfuse Therapeutics), an endothelin antagonist, was delivered at low and high doses and compared with control, showing structure improvements in macular ischemia, leakage and microaneurysms.

Perfuse Therapeutics' drug-device PER-001 shows promise in treating glaucoma and diabetic retinopathy, potentially restoring vision in patients.

Perfuse Therapeutics, Inc., a biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, today announced positive results from two Phase 2 clinical ...

SAN FRANCISCO, June 24, 2025 /PRNewswire/ -- Perfuse Therapeutics, Inc., a biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, today ...

The estimated time to fully perfuse this capillary network was 193 s, which corroborates the values reported in the literature. We then modeled the capillary network as an empirically determined ...

Zachary Sexton and colleagues have developed a design platform that can rapidly generate vasculature trees that can then be bioprinted and used to successfully perfuse living tissue constructs ...